Institute for Cancer Vaccines and Immunotherapy

Registered charity 1080343 · since 2000icvi.org.uk·United Kingdom·Updated 31 October 2026

At a glance

Open to applications
Fixed application deadlines · unsolicited applications welcome

Key takeaways

  • This funder's stated focus is research into cancer immunotherapy and vaccines, with a priority on work in the UK, so a charity whose work sits outside that area is unlikely to fit.
  • It funds specific research projects led by scientists and clinicians at highly-rated research institutions, and major grants require at least a PhD and a senior researcher's support at the applicant's institution, so a small nonprofit would likely need a research partner to lead the application.
  • The annual report gives no grant total or typical grant size, so a realistic request cannot be judged from the annual report, though project grants are typically three years long and the budget should reflect that.
  • Applications are made in full with lay abstracts, and funding calls are issued only occasionally, so check for an open call before writing.
  • Proposals go to international peer review for scientific merit and translational impact, so the case should rest on the science.

Overview

Institute for Cancer Vaccines and Immunotherapy is a charity registered with the Charity Commission for England and Wales (charity number 1080343).

The Cancer Vaccine Institute, now the Institute for Cancer Vaccines and Immunotherapy, was launched by a group of grateful patients as an independent charity. Its objective is to fund research into immunotherapy as a treatment for cancer, through research projects that are typically three years in duration. It relies solely on voluntary donations, and says it needs £600k each year to keep its research work going.

What they fund

Priority Areas

The foundation funds research into cancer immunotherapy and vaccines to improve survival and quality of life for patients across a wide range of cancers. It supports specific research projects led by scientists and clinicians at highly-rated research institutions, and focuses its resources on research in the UK. Its strategy seeks a broader base of research, new approaches and translation of discoveries into patient benefit. Proposals are assessed through expert peer review for scientific merit against its strategy, collaboration with others supported by ICVI, intellectual innovation and translational research. It encourages work that can reduce the long-term cost of cancer treatment and supports collaboration and the careers of young scientists. Research project grants are typically three years in duration.

Themes

  • Cancer immunotherapy
  • Cancer vaccines
  • Drug repurposing
  • Non-classical T-cell approaches
  • Immune checkpoint therapy

Geographic Focus

Priority: The UK.

How to apply

Candidates submit a full application for international peer review; the Peer Review Committee scores applicants according to eligibility.

Deadlines: Funding calls are issued occasionally.

Who can apply:

  • Applicants for major grants should at least have a PhD qualification and the support of a senior researcher at their institution.

What to send:

  • A full application
  • “lay abstracts” – short project descriptions written in everyday language

Application success factors

What the charity says:

  • The foundation intends to fund research at highly-rated research institutions, assessed primarily through the Research Excellence Framework.
  • Applicants for major grants should have at least a PhD and support from a senior researcher at their institution.
  • Proposals are assessed for scientific merit against the strategy, collaboration with others supported by ICVI, intellectual innovation and translational research.
  • Peer reviewers consider whether applicants can deliver the project, its technical strengths and weaknesses, its methodology and likely impact.

Where they fund

Where it says it funds

  • United Kingdom

Similar funders

Funders supporting work similar to Institute for Cancer Vaccines and Immunotherapy.

Five years of accounts

Financial yearIncomeExpenditureGrants paidAccounts document
year to 31 March 2021£685,032£794,179—Accounts for year to 31 March 2021
year to 31 March 2022£566,386£743,574—Accounts for year to 31 March 2022
year to 31 March 2023£620,770£584,936—Accounts for year to 31 March 2023
year to 31 March 2024£260,774£577,644—Accounts for year to 31 March 2024
year to 31 March 2025£433,030£547,097—Accounts for year to 31 March 2025

— No grants figure for those years.

Figures from the charity’s filed accounts and its register entry. The document icon links to the charity’s entry on the Charity Commission register, where its filed accounts can be found.

Sources

Other sources

This profile draws on the funder’s own website as well as its filed accounts.

Sources last checked on 31 October 2026.

🎯 You've done the research. Now write an application they can't refuse.

Hinchilla combines funder's specific priorities with your organisation's past successful grants and AI analysis of what reviewers want to see.

✓

Data privacy and security by default

✓

Your organisation's past successful grants and experience

✓

AI analysis of what reviewers want to see

✓

A compelling draft application in 10 minutes instead of 10 hours

Spotted something that needs correcting? Let us know

Stay Updated

Get updates on Institute for Cancer Vaccines and Immunotherapy and other funders

Subscribe
Helpful Hinchilla

Applying to Institute for Cancer Vaccines and Immunotherapy?

Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.

Start your 4-week free trial

No credit card required

Contact